Development of a simple HPLC-UV method for the determination of the hepatitis C virus inhibitor simeprevir in human plasma.

[1]  S. Ouwerkerk-Mahadevan,et al.  Drug–Drug Interactions with the NS3/4A Protease Inhibitor Simeprevir , 2015, Clinical Pharmacokinetics.

[2]  J. Feld,et al.  Hepatitis C virus infection , 2015, Canadian Medical Association Journal.

[3]  S. Ouwerkerk-Mahadevan,et al.  Evaluation of the Pharmacokinetics and Renal Excretion of Simeprevir in Subjects with Renal Impairment , 2015, Drugs in R&D.

[4]  N. Partovi,et al.  Drug Interactions With Direct-Acting Antivirals for Hepatitis C , 2015, The Annals of pharmacotherapy.

[5]  R. Vries,et al.  Determination of simeprevir: a novel, hepatitis C protease inhibitor in human plasma by high-performance liquid chromatography-tandem mass spectrometry. , 2014, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[6]  B. Samuelsson,et al.  Discovery and development of simeprevir (TMC435), a HCV NS3/4A protease inhibitor. , 2014, Journal of medicinal chemistry.

[7]  G. Palù,et al.  Measurement of ribavirin and evaluation of its stability in human plasma by high-performance liquid chromatography with UV detection. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[8]  Charles M. Rice,et al.  Flaviviridae :T he Viruses and Their Replication , 2007 .

[9]  G. Palù,et al.  Simple determination of the HIV protease inhibitor atazanavir in human plasma by high-performance liquid chromatography with UV detection. , 2006, Journal of pharmaceutical and biomedical analysis.

[10]  Dieter Häussinger,et al.  Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. , 2002, The New England journal of medicine.

[11]  Kenneth Koury,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .

[12]  J. Chermann,et al.  INACTIVATION OF LYMPHADENOPATHY-ASSOCIATED VIRUS BY HEAT, GAMMA RAYS, AND ULTRAVIOLET LIGHT , 1985, The Lancet.